StonvexLoading…
StonvexStonvexStonvexCore line items from BKV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $376.55M | $893.78M | $635.97M | $436.20M |
Operating Income | $86.03M | $217.61M | $116.99M | $34.70M |
Net Income | $44.08M | $173.13M | $102.76M | $25.91M |
EPS (Diluted) | $0.42 | $1.98 | $1.20 | $0.30 |
Total Assets | $4.17B | $3.94B | $2.89B | $2.30B |
Total Liabilities | $1.86B | $1.87B | $1.09B | $716.37M |
Cash & Equivalents | $288.54M | $248.43M | $83.11M | $21.43M |
Free Cash Flow OCF − CapEx | $-34.54M | $-57.46M | $-35.65M | $91.28M |
Shares Outstanding | 109.39M | 96.87M | 89.97M | 84.71M |